White Paper
Download this white paper to explore how direct-to-patient (DTP) models are rapidly reshaping pharmaceutical commercialization strategies.
In this thought leadership paper, The Dedham Group examines the key drivers behind the rise of DTP and outlines three strategic considerations pharma leaders must address to successfully design, scale, and govern DTP models. Topics include patient and product fit, channel and fulfillment design, regulatory and policy implications, and contracting considerations that can materially impact access and revenue outcomes.
